Abstracts tagged "Healthcare system and rheumatoid arthritis (RA)"

Abstract Number: 1477 • 2018 ACR/ARHP Annual Meeting
Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. a Simulation Study in the United States of America
Barbara Mascialino¹, Sascha Swiniarski², Isabel Gehring³, Maryam Poorafshar¹ and Teresa Tarrant⁴, ¹Thermo Fisher Scientific, Uppsala, Sweden, Uppsala, Sweden, ²Thermo Fisher Scientific, Freiburg, Germany, Freiburg, Germany, ³Thermo Fisher Scientific, Freiburg, Germany, ⁴Division of Rheumatology and Immunology, Duke School of Medicine, Durham, NC
Serum Autoantibody Multi-Analyte Testing in Rheumatoid Arthritis Can Reduce Avoidable Costs Associated from False Positive Results. A Simulation Study in the United States of AmericaBarbara…
Abstract Number: 2268 • 2015 ACR/ARHP Annual Meeting
Peripheral Joint MRI for Inflammatory Arthritis and the Choosing Wisely Campaign – Evidence for Wide Variations in Use
Gabriela Schmajuk¹, Chris Tonner², Sara G. Murray³ and Jinoos Yazdany⁴, ¹Medicine / Rheumatology, UCSF / San Francisco VA, San Francisco, CA, ²Rheumatology, University of California, San Francisco, San Francisco, CA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴Rheumatology, UCSF, SF, CA
Background/Purpose: The Choosing Wisely campaign, which commenced in 2011, focuses on reducing medical services that are of questionable value or may be harmful. In 2013,…
Abstract Number: 186 • 2013 ACR/ARHP Annual Meeting
Delay In Consultation and Starting Disease Modifying Anti-Rheumatic Drugs In Patients With Rheumatoid Arthritis In Argentina. How Early Arthritis Clinics Impact On Health Barriers?
Natalia Zamora¹, Christian A. Waimann², Maria Florencia Marengo², Gustavo Citera¹, Amelia Granel³, Ana Inés Marcos³, Emilio Buschiazzo⁴, Ricardo V. Juarez⁵, Dora Pereira⁶, Gisela Pendón⁶, Andrea D'Orazio⁷, Mariana Salcedo⁸, Judith Sarano⁹, María Victoria Collado⁹, Graciela Gómez¹⁰, Alejandra Medina¹¹, María Eugenia Lara¹², Juan C. Barreira¹², María Alicia Lázaro¹³, Alejandra Cusa¹³, Luciana González Lucero¹⁴, María Silvia Yacuzzi¹⁴, Raúl Nicolas Martínez¹⁵ and Pablo Arturi¹⁶, ¹Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ²Rheumatology section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, ³Rheumatology, Hospital San Roque de Gonnet, La Plata, La Plata, Argentina, ⁴Rheumatology, Hospital Señor del Milagro, Salta, Argentina, ⁵Rheumatology Section, Hospital Señor del Milagro, Salta, Argentina, ⁶Hospital Ricardo Gutierrez, La Plata, La Plata, Argentina, ⁷rheumatology, Hospital Municipal de agudos Dr. Leonidas Lucero, Bahía Blanca, Argentina, ⁸Consultorio Privado, San Nicolás, Argentina, ⁹Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹⁰Rheumatology, Instituto de Investigaciones Medicas Alfredo Lanari, Buenos Aires, Argentina, ¹¹Hospital General de Agudos "Dr. E. Tornu", Ciudad Autónoma de Buenos Aires, Argentina, ¹²Rheumatology, British Hospital, Buenos Aires, Argentina, ¹³Hospital central de San isidro Dr A. Posse, San Isidro, Argentina, ¹⁴Hospital Angel Cruz Padilla, San Miguel de Tucumán, Argentina, ¹⁵Hospital Angel C. Padilla de San Miguel de Tucumán, San Miguel de Tucumán, Argentina, ¹⁶Hospital Italiano de La Plata, La Plata, Argentina
Background/Purpose: An early and intensive treatment has become the cornerstone in the treatment of Rheumatoid Arthritis (RA). For this reason, an early consult with a rheumatologist is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].